Related Experiment Video

Updated: Aug 6, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Cooperation to amplify gene-dosage-imbalance effects

Susana de la Luna1, Xavier Estivill

  • 1ICREA and Gene Function Group, Genes and Disease Program, Center for Genomic Regulation-CRG, 08003-Barcelona, Spain. susana.luna@crg.es

Trends in Molecular Medicine
|August 22, 2006
PubMed

Insights

Down syndrome (Trisomy 21) arises from gene overexpression on chromosome 21. Two key genes, DSCR1 and DYRK1A, interact to disrupt NFAT signaling, impacting multiple organ systems in individuals with Down syndrome.

Area of Science:

  • Genetics
  • Developmental Biology
  • Molecular Biology

Background:

  • Trisomy 21 (Down syndrome) is a genetic disorder affecting multiple organ systems.
  • The clinical features are hypothesized to result from the overexpression of specific genes on chromosome 21.
  • Understanding these genetic mechanisms is crucial for addressing Down syndrome.

Purpose of the Study:

  • To investigate the functional interaction between DSCR1 and DYRK1A genes in the context of Trisomy 21.
  • To elucidate the role of these genes in the dysregulation of NFAT signaling pathways.
  • To explore the molecular basis for the multi-organ effects observed in Down syndrome.

Main Methods:

  • Analysis of gene expression and protein interactions.
  • Investigating the functional interplay between DSCR1 and DYRK1A.
  • Studying the impact on NFAT signaling pathways.

Main Results:

  • Compelling evidence shows DSCR1 and DYRK1A protein products interact functionally.
  • Increased dosage of DSCR1 and DYRK1A cooperatively dysregulates NFAT signaling pathways.
  • This dysregulation has potential consequences for organ systems affected in Down syndrome.

Conclusions:

  • The functional interaction and dosage of DSCR1 and DYRK1A are key contributors to Trisomy 21 pathogenesis.
  • Dysregulation of NFAT signaling by these genes offers a molecular explanation for Down syndrome's complex phenotype.
  • Further research into these pathways may reveal therapeutic targets for Down syndrome.

More Related Videos

A Reverse Genetic Approach to Test Functional Redundancy During Embryogenesis06:59

A Reverse Genetic Approach to Test Functional Redundancy During Embryogenesis

Published on: August 11, 2010

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

Related Concept Videos

Gene Conversion02:08

Gene Conversion

Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Dosage Compensation02:50

Dosage Compensation

In animals, gender is determined by the number and type of sex chromosome. For example, human females have two X chromosomes, and males have one X and one Y chromosome, whereas C.elegans with one X chromosome is a male, and the one with two X chromosomes is a hermaphrodite.
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with  distinct numbers of X chromosomes will have...